Vanda Pharmaceuticals Inc. (VNDA)
NGM – Real Time Price. Currency in USD
5.14
+0.20 (4.16%)
Market open: Aug 12, 2026, 12:32 PM EDT
5.02
+0.09 (1.83%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
5.14
+0.20 (4.16%)
Market open: Aug 12, 2026, 12:32 PM EDT
5.02
+0.09 (1.83%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $56.0M significantly exceed its total debt $22.8M, ensuring strong financial flexibility
Total current assets $264.5M exceed Total current liabilities $164.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$31.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.61 | 6.05 | 8.0 | |
| Quick ratio | 1.60 | 5.63 | 8.0 | |
| Debt to Equity | 0.10 | 0.30 | 9.0 | |
| Debt to Assets | 0.06 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 254M | 193M | 199M | 216M | 216M |
| Gross Profit | 229M | 176M | 180M | 196M | 193M |
| Operating Income | 6M | -14M | -41M | -151M | -186M |
| Net Income | 6M | 3M | -19M | -220M | -275M |
| EBITDA | 9M | -11M | -33M | -139M | -171M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 24.07 | -61.18 | 5.5 |
| Next quarter | 36.94 | 82.43 | 10 |
| Current year | 17.29 | 26.34 | 9.5 |
| Next year | 36.18 | 67.88 | 10 |
| Weighted average score | 8.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -2.29 | -28.7 | -26.82 | 38.02 | 3.3 |
| Y/Y | -3.91 | -129.76 | -126.08 | -101.01 | 1.0 |
| 3y average | -4.11 | -659.93 | -673.97 | -290.29 | 1.0 |
| 5y average | -1.87 | -403.75 | -412.96 | -178.86 | 1.0 |
| Weighted average score | 1.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |